Frontlight ResearchEarly access
Trial site
Retina-Vitreous Surgeons of Central New York
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration5 trials
- Diabetic eye disease3 trials
- Phase
- Phase 35 trials
- Phase 2/32 trials
- Phase 21 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Recruiting1 trial
- Lead sponsor
- Hoffmann-La Roche2 trials
- Janssen Research & Development, LLC2 trials
- 4D Molecular Therapeutics1 trial
- Astellas Pharma Global Development, Inc.1 trial
- Ocular Therapeutix, Inc.1 trial
- and 1 more
Running trials
Active, not recruiting
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration1 recruiting
Closed trials
Completed
Completed
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026